Prosecution Insights
Last updated: May 29, 2026

Rohto Pharmaceutical Co. Ltd.

6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
3
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (83%)
0
Easy (0%)
1
Unknown (17%)

Rejection Statute Mix

BucketCases
§103 only5 (83%)
No statute on record1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

6
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ABBAS, ABDULRAHMAN MUSTAFA 1 54.4% +39.2%
VIGIL, TORIANA NICHOLE 1 53.2% +21.4%
SASAN, ARADHANA 1 64.4% +26.4%
FAY, ZOHREH ALEMZADEH 1 51.8% -6.7%
WELLES, COLMAN THOMAS 1 33.3% +76.9%
HUANG, GIGI GEORGIANA 1 31.8% +30.4%

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17632419 Ophthalmic Composition for Promoting Tear Secretion HUANG, GIGI GEORGIANA 147d overdue
18018105 Aqueous Composition WELLES, COLMAN THOMAS 49d overdue
18695745 OPHTHALMOLOGICAL COMPOSITION VIGIL, TORIANA NICHOLE 22d overdue
18023119 COMPOSITION FOR AMELIORATING UNPLEASANT STATE CAUSED BY MENSTRUATION SASAN, ARADHANA 11d overdue
18709382 OIL-BASED SOLID COMPOSITION FOR EXTERNAL USE ABBAS, ABDULRAHMAN MUSTAFA 39d

Top Art Units

Art UnitApps
1612 3
1615 1
1617 1
1613 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18709382 OIL-BASED SOLID COMPOSITION FOR EXTERNAL USE ABBAS, ABDULRAHMAN MUSTAFA 1612 §103 Non-Final OA 39d Pending May 10, 2024
18695745 OPHTHALMOLOGICAL COMPOSITION VIGIL, TORIANA NICHOLE 1612 §103 Non-Final OA 22d overdue Pending Mar 26, 2024
18023119 COMPOSITION FOR AMELIORATING UNPLEASANT STATE CAUSED BY MENSTRUATION SASAN, ARADHANA 1615 §103 Non-Final OA 11d overdue Pending Feb 24, 2023
18018108 Aqueous Composition FAY, ZOHREH ALEMZADEH 1617 §103 Final Rejection 24d overdue Pending Jan 26, 2023
18018105 Aqueous Composition WELLES, COLMAN THOMAS 1612 Other Final Rejection 49d overdue Pending Jan 26, 2023
17632419 Ophthalmic Composition for Promoting Tear Secretion HUANG, GIGI GEORGIANA 1613 §103 Final Rejection 147d overdue Pending Feb 02, 2022

Managing Rohto Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month